Immunocure Discovery Solutions
About:
AI & Computational Platform AxDrug for Drug Discovery
Website: https://immunocure.us
Twitter/X: ImmunocureDS
Description:
Immunocure develops an AI platform AxDrug to design and discover new drugs for cancer and other diseases integrated with in-house chemistry facility.
Total Funding Amount:
$1.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Brooklyn, New York, United States
Founded Date:
2020-01-25
Contact Email:
info(AT)immunocure.us
Founders:
Dr. Ravi Kumar Muttineni
Number of Employees:
11-50
Last Funding Date:
2023-06-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai